Transport of opioid peptides into the central nervous system.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Pharmacy and Science

• Publication date

  1998-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JS980062BPMID 9811502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation of a heptapeptide Val-Val-Tyr-Pro-Trp-Thr-Gln (valorphin) with some opiate activity.

  2009cited by this paper
• Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier

  2004cited by this paper
• Bioavailability and transport of peptides and peptide drugs into the brain.

  1997cited by this paper
• Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.

  1997cited by this paper
• Brain and Spinal Cord Distribution of Biphalin: Correlation with Opioid Receptor Density and Mechanism of CNS Entry

  1997cited by this paper
• Receptor-induced Internalization of Selective Peptidic μ and δ Opioid Ligands*

  1997cited by this paper
• SYNTHESIS OF A NOVEL ESTERASE-SENSITIVE CYCLIC PRODRUG OF A HEXAPEPTIDE USING AN (ACYLOXY)ALKOXY PROMOIETY

  1997cited by this paper
• Receptor-induced internalization of selective peptidic mu and delta opioid ligands.

  1997cited by this paper
• The entry of [D-penicillamine2,5]enkephalin into the central nervous system: saturation kinetics and specificity.

  1997cited by this paper
• Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability.

  1997cited by this paper
• Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.

  1996cited by this paper
• THE EFFECT OF GLYCOSYLATION ON THE UPTAKE OF AN ENKEPHALIN ANALOGUE INTO THE CENTRAL NERVOUS SYSTEM

  1996cited by this paper
• Physiology of the CSF and Blood-Brain Barriers

  1996cited by this paper
• Passage of a δ‐Opioid Receptor Selective Enkephalin, [d‐Penicillamine2,5]Enkephalin, Across the Blood‐Brain and the Blood‐Cerebrospinal Fluid Barriers

  1996cited by this paper
• Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design.

  1996cited by this paper
• Carrier-mediated transport of the antitumor agent acivicin across the blood-brain barrier.

  1995cited by this paper
• Permeability of the developing blood-brain barrier to 14C-mannitol using the rat in situ brain perfusion technique.

  1995cited by this paper
• Accelerated communciation: Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence

  1994cited by this paper
• Identification and distribution of insulin receptors on cultured bovine brain microvessel endothelial cells: Possible function in insulin processing in the blood–brain barrier

  1994cited by this paper
• Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.

  1994cited by this paper
• Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence.

  1994cited by this paper
• Effect of peptidases at the blood brain barrier on the permeability of enkephalin.

  1994cited by this paper
• Peptidases, Peptides, and the Mammalian Blood–Brain Barrier

  1993cited by this paper
• Antinociceptive profile of biphalin, a dimeric enkephalin analog.

  1993cited by this paper
• Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs.

  1993cited by this paper
• Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration.

  1992cited by this paper
• Ultrastructure of Brain Endothelium

  1992cited by this paper
• Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration.

  1991cited by this paper
• Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.

  1990cited by this paper
• Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins

  1990cited by this paper
• Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.

  1990cited by this paper
• Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study.

  1990cited by this paper
• Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers.

  1990cited by this paper
• Fluid-phase endocytosis by primary cultures of bovine brain microvessel endothelial cell monolayers.

  1990cited by this paper
• Kinetic Analysis of Leucine‐Enkephalin Cellular Uptake at the Luminal Side of the Blood‐Brain Barrier of an In Situ Perfused Guinea‐Pig Brain

  1989cited by this paper
• Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.

  1989cited by this paper
• Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.

  1989cited by this paper
• Blood-brain barrier passage of azidothymidine in rats: effect of insulin.

  1989cited by this paper
• Exchange diffusion of large neutral amino acids between blood and brain

  1988cited by this paper
• Measurement of Solute Transport Across the Blood–Brain Barrier in the Perfused Guinea Pig Brain: Method and Application to N‐Methyl‐α‐Aminoisobutyric Acid

  1986cited by this paper
• Characterization of an In Vitro Blood–Brain Barrier Model System for Studying Drug Transport and Metabolism

  1986cited by this paper
• Kinetic Analysis of Cerebrovascular Isoleucine Transport from Saline and Plasma

  1985cited by this paper
• Kinetic analysis of L-leucine transport across the blood-brain barrier.

  1984cited by this paper
• Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.

  1983cited by this paper
• Modulation of substrate transport to the brain

  1983cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper
• Electrical resistance of a capillary endothelium

  1981cited by this paper
• High‐ and Low‐Affinity Transport of D‐Glucose from Blood to Brain

  1981cited by this paper
• Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells.

  1981cited by this paper

• Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases?

  2021cites this paper
• Novel Cyclic Endomorphin Analogues with Multiple Modifications and Oligoarginine Vector Exhibit Potent Antinociception with Reduced Opioid-like Side Effects.

  2021cites this paper
• Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP)

  2019cites this paper
• The neuroprotective role of the brain opioid system in stroke injury.

  2018cites this paper
• Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.

  2016cites this paper
• Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.

  2015cites this paper
• Crypteins--an overlooked piece of peptide systems.

  2015cites this paper
• Novel endomorphin-1 analogs with C-terminal oligoarginine-conjugation display systemic antinociceptive activity with less gastrointestinal side effects.

  2015cites this paper
• Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain

  2014cites this paper
• Bioavailability of endomorphins and the blood-brain barrier--a review.

  2013cites this paper
• Nanofiber-based delivery of therapeutic peptides to the brain.

  2013cites this paper
• Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation.

  2013cites this paper
• Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation.

  2013cites this paper
• Synthesis and biological evaluation of an orally active glycosylated endomorphin-1.

  2012cites this paper
• Loperamide Effects on Anxiety Level and Feeding Behavior in Rats. Role of Vagal Afferentation

  2012cites this paper
• Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation

  2012cites this paper
• The analgesic activity of biphalin and its analog AM 94 in rats.

  2012cites this paper
• Synthesis, biological activity and structure-activity relationship of endomorphin-1/substance P derivatives.

  2012cites this paper
• Structure-activity relationships of biphalin analogs and their biological evaluation on opioid receptors.

  2012cites this paper
• Microinjection of HSV-1 Amplicon Vector-Mediated Human Proenkephalin into the Periaqueductal Grey Attenuates Neuropathic Pain in Rats

  2012cites this paper
• Effects of Peripherally Acting Opioid Ligands on Central Opioid Receptors and β-Endorphin Release in Stressed Rats

  2012cites this paper
• Estudio del efecto de la autoadministración de morfina y endomorfina-2 en animales con distinta vulnerabilidad a las acciones reforzantes de los opiáceos

  2012cites this paper
• The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.

  2012cites this paper
• cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2.

  2012cites this paper
• Intrathecal herpes simplex virus type 1 amplicon vector-mediated human proenkephalin reduces chronic constriction injury-induced neuropathic pain in rats.

  2011cites this paper
• Turning Endogenous Peptides into New Analgesics: The Example of Kyotorphin Derivatives

  2011cites this paper
• Desirability function combining metabolic stability and functionality of peptides

  2011cites this paper
• Peripheral Administration of Loperamide and Methylnaloxone Decreases the Degree of Anxiety in Rats

  2010cites this paper
• Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides.

  2010cites this paper
• The Analgesic Activity of Bestatin as a Potent APN Inhibitor

  2010cites this paper
• Modulation of Peripheral Opioid Receptors Affects the Concentration of μ-Opioid Receptors in Rat Brain

  2009cites this paper
• Respiratory and cardiovascular effects of biphalin in anaesthetized rats.

  2009cites this paper
• Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2.

  2009cites this paper
• Modification with Organometallic Compounds Improves Crossing of the Blood–Brain Barrier of [Leu5]‐Enkephalin Derivatives in an In Vitro Model System

  2009cites this paper
• SELECTIVE NON-PEPTIDE MU-OPIOID RECEPTOR ANTAGONIST: DESIGN, SYNTHESIS AND BIOLOGICAL STUDIES

  2008cites this paper
• Enzymatic degradation of endomorphins.

  2008cites this paper
• The Endomorphin System and Its Evolving Neurophysiological Role

  2007cites this paper
• Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.

  2007cites this paper
• Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells.

  2007cites this paper
• Synthesis and pharmacological analysis of a morphine/substance P chimeric molecule with full analgesic potency in morphine-tolerant rats.

  2007cites this paper
• Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges

  2006cites this paper
• In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail‐withdrawal assay

  2006cites this paper
• Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2.

  2005cites this paper
• Glycosylated neuropeptides: A new vista for neuropsychopharmacology?

  2005cites this paper
• Synthesis and biological activity of N-methylated analogs of endomorphin-2.

  2005cites this paper
• Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats.

  2004cites this paper
• Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.

  2004cites this paper
• The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood–brain barrier and exhibits anticonvulsive effects

  2004influential citation
• Conotoxins and structural biology: a prospective paradigm for drug discovery.

  2004cites this paper
• Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesia.

  2004cites this paper
• Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline.

  2003cites this paper
• Potency Differences ford-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2as an Antagonist of Peptide and Alkaloid μ-Agonists in an Antinociception Assay

  2003cites this paper
• Glycopeptide-membrane interactions: glycosyl enkephalin analogues adopt turn conformations by NMR and CD in amphipathic media.

  2003cites this paper
• Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile.

  2003cites this paper
• Biphalin: A Multireceptor Opioid Ligand

  2003cites this paper
• Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.

  2002cites this paper
• Effect of cerebral ventricles perfusion with morphiceptin and Met-enkephalin on trigemino-hypoglossal reflex in rats.

  2002cites this paper
• Potency Differences for D -Phe-Cys-Tyr- D -Trp-Arg-Thr-Pen-Thr-NH 2 as an Antagonist of Peptide and Alkaloid (cid:1) -Agonists in an Antinociception Assay

  2002cites this paper
• Potency Differences for D -Phe-Cys-Tyr- D -Trp-Arg-Thr-Pen-Thr-NH 2 as an Antagonist of Peptide and Alkaloid (cid:1) -Agonists in an Antinociception Assay

  2002cites this paper
• Investigation of substance P transport across the blood-brain barrier.

  2002cites this paper
• Theories of addiction.

  2001cites this paper
• Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect.

  2000cites this paper
• Enkephalins Are Transported by a Novel Eukaryotic Peptide Uptake System*

  2000cites this paper
• Specific Mechanisms for Transporting Drugs Into Brain

  2000cites this paper
• Assessment of Stereoselectivity of Trimethylphenylalanine Analogues of δ‐Opioid [D‐Pen2,D‐Pen5]‐Enkephalin

  2000cites this paper
• Experimental methods for studying drug uptake in the head and brain.

  2000cites this paper
• Transporter-mediated permeation of drugs across the blood-brain barrier.

  2000cites this paper
• Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin.

  2000cites this paper
• Transport of the delta-opioid receptor agonist [D-penicillamine2,5] enkephalin across the blood-brain barrier involves transcytosis1.

  1999cites this paper